A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial (Q36663561)

15 August 2017

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial (English)

1 reference

15 August 2017

1 reference

S Bowden

5

0 references

Carlos Caldas

10

object named as

C Caldas

1 reference

15 August 2017

E Provenzano

1

1 reference

15 August 2017

A-L Vallier

2

1 reference

15 August 2017

R Champ

3

1 reference

15 August 2017

K Walland

4

1 reference

15 August 2017

A Grier

6

1 reference

15 August 2017

N Fenwick

7

1 reference

15 August 2017

J Abraham

8

1 reference

15 August 2017

M Iddawela

9

1 reference

15 August 2017

L Hiller

11

1 reference

15 August 2017

J Dunn

12

1 reference

15 August 2017

H M Earl

13

1 reference

15 August 2017

language of work or name

English

0 references

publication date

8 January 2013

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

108

1 reference

15 August 2017

4

1 reference

15 August 2017

866-872

1 reference

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Who would have thought a single Ki67 measurement would predict long-term outcome?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Preoperative chemotherapy treatment of breast cancer--a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.

30 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

Clinical significance of axillary microresiduals after neoadjuvant chemotherapy in breast cancer patients with cytologically proven metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.547

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3590651

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

20 September 2018

1 reference

12 December 2020

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome

1 reference

12 December 2020

The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer

1 reference

12 December 2020

American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome

1 reference

12 December 2020

Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy

1 reference

12 December 2020

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

1 reference

12 December 2020

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation

1 reference

12 December 2020

Prognostic value of initial clinical disease stage after achieving pathological complete response

1 reference

12 December 2020

Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients

1 reference

12 December 2020

The Pathologic Complete Response Open Question in Primary Therapy

1 reference

12 December 2020

Predictive Immunohistochemical Biomarkers in the Context of Neoadjuvant Therapy for Breast Cancer

1 reference

12 December 2020

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.547

1 reference

release_xtqb26mnanew7ekuley32mygte

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xtqb26mnanew7ekuley32mygte

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

23299526

1 reference